Regeneron Pharmaceuticals Management
Management criteria checks 3/4
Regeneron Pharmaceuticals' CEO is Leonard Schleifer, appointed in Jan 1988, has a tenure of 36.67 years. total yearly compensation is $8.18M, comprised of 22.9% salary and 77.1% bonuses, including company stock and options. directly owns 2.22% of the company’s shares, worth $2.50B. The average tenure of the management team and the board of directors is 7 years and 17.8 years respectively.
Key information
Leonard Schleifer
Chief executive officer
US$8.2m
Total compensation
| CEO salary percentage | 22.9% |
| CEO tenure | 36.7yrs |
| CEO ownership | 2.2% |
| Management average tenure | 7yrs |
| Board average tenure | 17.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$4b |
| Mar 31 2024 | n/a | n/a | US$4b |
| Dec 31 2023 | US$8m | US$2m | US$4b |
| Sep 30 2023 | n/a | n/a | US$4b |
| Jun 30 2023 | n/a | n/a | US$4b |
| Mar 31 2023 | n/a | n/a | US$4b |
| Dec 31 2022 | US$7m | US$2m | US$4b |
| Sep 30 2022 | n/a | n/a | US$5b |
| Jun 30 2022 | n/a | n/a | US$6b |
| Mar 31 2022 | n/a | n/a | US$8b |
| Dec 31 2021 | US$6m | US$2m | US$8b |
| Sep 30 2021 | n/a | n/a | US$7b |
| Jun 30 2021 | n/a | n/a | US$6b |
| Mar 31 2021 | n/a | n/a | US$4b |
| Dec 31 2020 | US$135m | US$1m | US$4b |
| Sep 30 2020 | n/a | n/a | US$3b |
| Jun 30 2020 | n/a | n/a | US$3b |
| Mar 31 2020 | n/a | n/a | US$2b |
| Dec 31 2019 | US$21m | US$1m | US$2b |
| Sep 30 2019 | n/a | n/a | US$2b |
| Jun 30 2019 | n/a | n/a | US$2b |
| Mar 31 2019 | n/a | n/a | US$2b |
| Dec 31 2018 | US$27m | US$1m | US$2b |
| Sep 30 2018 | n/a | n/a | US$2b |
| Jun 30 2018 | n/a | n/a | US$2b |
| Mar 31 2018 | n/a | n/a | US$1b |
| Dec 31 2017 | US$27m | US$1m | US$1b |
Compensation vs Market: Leonard's total compensation ($USD8.18M) is above average for companies of similar size in the PE market ($USD5.68M).
Compensation vs Earnings: Leonard's compensation has been consistent with company performance over the past year.
CEO
Leonard Schleifer (71 yo)
36.7yrs
Tenure
US$8,184,338
Compensation
Dr. Leonard S. Schleifer, M.D., Ph D., Co-founded Regeneron Pharmaceuticals, Inc. in 1988 and has been its President and Chief Executive Officer since 1988 and is its Board Co-Chair since June 2023. He ser...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 36.7yrs | US$8.18m | 2.22% $ 2.5b | |
| Co-Founder | 23.7yrs | US$7.76m | 1.07% $ 1.2b | |
| Executive Vice President of Research | 5.7yrs | US$8.43m | 0.049% $ 54.9m | |
| Executive VP and GM of Industrial Operations & Product Supply | 16.4yrs | US$8.76m | 0.031% $ 35.3m | |
| Senior VP of Finance & CFO | less than a year | no data | 0.017% $ 19.6m | |
| Senior Vice President of Quality Assurance & Operations | 4.7yrs | no data | no data | |
| Senior VP of IT & Chief Information Officer | 3.7yrs | no data | no data | |
| Senior Vice President of Investor Relations & Strategic Analysis | no data | no data | no data | |
| Executive VP | 13yrs | US$7.13m | 0.035% $ 39.9m | |
| Senior VP & Chief Compliance Officer | 1.7yrs | no data | no data | |
| Senior Vice President of Corporate Affairs | no data | no data | no data | |
| Executive Vice President of Human Resources | 8.4yrs | no data | no data |
7.0yrs
Average Tenure
64.5yo
Average Age
Experienced Management: REGN's management team is seasoned and experienced (7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 36.7yrs | US$8.18m | 2.22% $ 2.5b | |
| Co-Founder | 23.7yrs | US$7.76m | 1.07% $ 1.2b | |
| Lead Independent Director | 13.8yrs | US$748.01k | 0.00073% $ 821.6k | |
| Independent Director | 21.7yrs | US$724.99k | 0.016% $ 18.4m | |
| Independent Director | 33.3yrs | US$728.99k | 0.012% $ 13.1m | |
| Independent Director | 33.3yrs | US$709.99k | 0.0046% $ 5.2m | |
| Independent Director | 36.7yrs | US$724.99k | 0.026% $ 29.6m | |
| Independent Director | 7.7yrs | US$704.99k | 0.000010% $ 11.3k | |
| Independent Director | 1.9yrs | US$247.79k | 0% $ 0 | |
| Independent Director | 8yrs | US$714.99k | 0% $ 0 | |
| Independent Director | 8yrs | US$709.99k | 0.0013% $ 1.4m | |
| Independent Director | less than a year | US$1.03m | 0% $ 0 |
17.8yrs
Average Tenure
71yo
Average Age
Experienced Board: REGN's board of directors are seasoned and experienced ( 17.8 years average tenure).